1018969-88-4Relevant articles and documents
COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
-
, (2022/03/22)
The present disclosure relates to copper complexes, pharmaceutical compositions comprising these complexes, chemical processes for preparing these complexes, and their use in the treatment of neurodegenerative disease, e.g., amyotrophic lateral sclerosis (ALS).
Aerobic oxidation of cyclopentane-1,2-diols to cyclopentane-1,2-diones on Pt/C catalyst
Reile, Indrek,Paju, Anne,Eek, Margus,Pehk, T?nis,Lopp, Margus
, p. 347 - 350 (2008/09/17)
A new method for the aerobic oxidation of cyclopentane-1,2-diols to corresponding 1,2-diones using heterogeneous Pt/C catalyst in the presence of LiOH is described. Different functional groups tolerate the oxidation conditions. Yields of 1,2-diones up to 76% were achieved. Georg Thieme Verlag Stuttgart.